ResearcherCapital Medical UniversityActive in the last 2 years

Huachong Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-0257-5793; OpenAlex author ID A5112888596. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation. Last author DOI 10.1016/j.gendis.2025.101702 ↗
A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases. Co-author DOI 10.31083/fbl40818 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Zhao · 2 shared papers, 2025 · strength 0.49
- Paper A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-… DOI 10.31083/fbl40818 ↗
- Paper Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative… DOI 10.1016/j.gendis.2025.101702 ↗
Yaheng Wu · 1 shared paper, 2025 · strength 0.26
- Paper A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-… DOI 10.31083/fbl40818 ↗
Ye Wu · 1 shared paper, 2025 · strength 0.23
- Paper Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative… DOI 10.1016/j.gendis.2025.101702 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.